文献速递脑血管病外科小儿神经外科与脑积水神经重症

布美他尼减轻蛛网膜下腔出血大鼠模型的急性脑积水

Bumetanide lowers acute hydrocephalus in a rat model of subarachnoid hemorrhage.
PubMed 文献 · Acta Neurochir (Wien) · 2022-01-30

研究使用94只Wistar大鼠,经血管内穿孔法诱导蛛网膜下腔出血(SAH),以MRI确认急性脑积水(AH)并将AH大鼠随机分为4组:对照组、上矢状窦(SSS)血栓形成组、脑室内注射生理盐水组和脑室内注射布美他尼组。结果显示50%存活SAH诱导的大鼠出现AH,其脑室体积与24小时功能结局相关(r=0.803),布美他尼使AH减少35.9%(p=0.002)。

要点

  • 50%存活SAH诱导的大鼠出现急性脑积水。
  • AH大鼠脑室体积与24小时神经功能评分相关(r=0.803)。
  • 脑室内注射布美他尼使AH减少35.9%(p=0.002)。

核心结论

  • 在啮齿类动物中,SAH后脑积水可能由脉络丛脑脊液分泌过多所致,脑室内注射布美他尼可限制该脑积水。
  • 不能排除其他机制参与SAH后急性脑积水。

研究设计与样本

  • 使用94只Wistar大鼠,经血管内穿孔技术诱导SAH,MRI确认AH,将AH大鼠随机分为4组:对照组、上矢状窦血栓形成组、脑室内注射生理盐水组和脑室内注射布美他尼组,24小时后再次MRI评估脑室体积并以神经功能评分评估临床结局。

主要发现

  • 50%存活SAH诱导的大鼠出现AH。
  • AH大鼠的脑室体积与24小时后功能结局相关(r=0.803)。
  • 在AH大鼠中,24小时后未接受任何进一步操作的对照组脑室体积保持同等程度增加。
  • 脑室内注射生理盐水或上矢状窦血栓形成对脑室体积无影响。
  • 脑室内注射布美他尼使AH减少35.9%(p=0.002)。

局限性

  • 不能排除其他机制参与SAH后急性脑积水。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subarachnoid hemorrhage (SAH) can lead to acute hydrocephalus (AH). AH pathophysiology is classically attributed to an obstruction of the arachnoid granulations by blood. Recent findings in rodents suggest that after intraventricular hemorrhage, AH is related to cerebrospinal fluid (CSF) hypersecretion by the choroid plexus (CP), as it can be reduced by intracerebroventricular (ICV) injection of bumetanide. OBJECTIVE: Here, we investigated if and how CSF hypersecretion and/or CSF outflow disorders contribute to post-SAH hydrocephalus. METHODS: Ninety-four Wistar rats were used. SAH was induced by the endovascular perforation technique. The presence of AH was confirmed by magnetic resonance imaging (MRI), and rats with AH were randomly assigned to 4 groups: control group, superior sagittal sinus (SSS) thrombosis to block CSF reabsorption, ICV injection of saline, and ICV injection of bumetanide to decrease CSF secretion. Clinical outcome was evaluated with a neuroscore. A second MRI was performed 24 h later to evaluate the ventricular volume. RESULTS: Fifty percent of rats that survived SAH induction had AH. Their ventricular volume correlated well to the functional outcome after 24 h (r = 0.803). In rats with AH, 24 h later, ventricular volume remained equally increased in the absence of any further procedure. Similarly, ICV injection of saline or SSS thrombosis had no impact on the ventricular volume. However, ICV injection of bumetanide reduced AH by 35.9% (p = 0.002). CONCLUSION: In rodents, post-SAH hydrocephalus is may be due to hypersecretion of CSF by the CP, as it is limited by ICV injection of bumetanide. However, we cannot exclude other mechanisms involved in post-SAH acute hydrocephalus.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Metayer T, Orset C, Ali C, et al. Bumetanide lowers acute hydrocephalus in a rat model of subarachnoid hemorrhage. Acta Neurochir (Wien). 2022. PMID: 35094147. doi:10.1007/s00701-021-05088-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。